Bido, Oka S.

HRN: 04-27-05  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2023
CO-AMOXICLAV 625MG (TAB)
10/12/2023
10/18/2023
PO
625 Mg Tab, 1 Tab
TID
Cap LR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: